OR WAIT 15 SECS
© 2021 MJH Life Sciences and Applied Clinical Trials Online. All rights reserved.
© 2021 MJH Life Sciences™ and Applied Clinical Trials Online. All rights reserved.
February 12, 2021
Life sciences companies challenged by need to minimize health risks without sacrificing data quality during pandemic.
View from Washington
FDA emphasizes importance of inclusion in trials.
President unveils lengthy program for combatting COVID-19 immediately following inauguration.
Click the title above for a link to open the Applied Clinical Trials January/February 2021 issue in an interactive PDF format.
Co-conveners of the newly formed Decentralized Trials & Research Alliance, Amir Kalali, MD and Craig Lipset discuss the alliance as well as how COVID-19 has impacted the industry.
Non-profit biotech organization Cure Rare Disease utilizes collaboration amidst COVID-19 pandemic to catalyze speed of therapeutic research.
From The Editor
A look forward to 2021 for the clinical trials industry.
Hybrid studies, patient-centric tools, and collaborations create big changes for clinical trials and stakeholders during COVID-19.
A compilation of recent notable news developments that pertain to the clinical trials industry.
View from Brussels
Cancer still a primary focus of EMA in light of COVID and vaccine development.
2020 Tufts CSDD – IBM Watson Health benchmarking study highlights need for new functionality from EDC solutions and providers.
A Closing Thought
COVID-19 speeds up clinical research and creates new advancements within industry.